Tag: Immunotherapy Market

February 28, 2019

Innovation in Breast Cancer Treatment: Combination and Off-the-Shelf Personalized Immunotherapies

Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf personalized immunotherapy
February 3, 2019

Checkpoint Inhibitors Driving the Immunotherapy Market

The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology.
October 7, 2018

BriaCell CEO: Building Offerings for the $30-billion Immunotherapy Market

BriaCell CEO Dr. William Williams discusses his company’s success in developing immunotherapies targeting breast and other cancers.